Table 4. Influence of gender and age on serum level of anti-rubella IgG in seropositive participants.
| gender | Age group (years) | Mean | Std. Deviation | N |
|---|---|---|---|---|
| male | 1–11 | 148,2071 | 118,01142 | 388 |
| 12–23 | 107,4753 | 104,88812 | 454 | |
| 24+ | 184,4087 | 127,10503 | 445 | |
| Total | 146,3559 | 121,16096 | 1.287 | |
| female | 1–11 | 158,7317 | 119,36821 | 323 |
| 12–23 | 108,8248 | 101,01651 | 472 | |
| 24+ | 186,5283 | 132,42313 | 445 | |
| Total | 149,7103 | 122,51995 | 1.240 | |
| Total | 1–11 | 152,9883 | 118,66190 | 711 |
| 12–23 | 108,1632 | 102,87936 | 926 | |
| 24+ | 185,4685 | 129,72264 | 890 | |
| Total | 148,0019 | 121,81713 | 2.527 |
The two-way ANOVA analysis was used to determine whether there is a statistically significant influence of gender and age on antibody levels in seropositive participants during the three observed periods.